US: ASTRAZENECA'S PRILOSEC DRUG SUFFERS SETBACK
Article Abstract:
AstraZeneca has suffered a setback for its drug Prilosec. US regulators questioned its suitability as an over-the-counter medicine. An advisory panel to the US Food and Drug Administration could not recommend Prilosec as an OTC heartburn drug until the long-term effects of using it were known. The drug might also mask gastric conditions preventing people seeking professional medical advice. AstraZeneca had been looking for OTC approval to extend the drug's sales life as it is about to come off patent in 2001. During 1999 Prilosec sold US$ 5.91bn in the US.
Publication Name: The Independent
Subject: Retail industry
ISSN: 0951-9467
Year: 2000
User Contributions:
Comment about this article or add new information about this topic:
US: GLAXO WELLCOME RECEIVES APPROVAL FROM FDA
Article Abstract:
Glaxo Wellcome, the
Publication Name: The Independent
Subject: Retail industry
ISSN: 0951-9467
Year: 2000
User Contributions:
Comment about this article or add new information about this topic:
US: FDA EXTENDS FOSCAN REVIEW PERIOD
Article Abstract:
The US Food and Drug and Drug Administration (FDA) has decided to extend the review period of the Foscan cancer treatment developed by the UK pharmaceuticals company, Scotia Holdings. The review period will now continue from July to October 2000.
Publication Name: The Independent
Subject: Retail industry
ISSN: 0951-9467
Year: 2000
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: UK: TAKEOVER RUMOURS LIFT C&W. UK: NORWEB TELECOM APPOINTS NEW MD. UK: GROWING POPULARITY OF MOBILE PHONES
- Abstracts: US: ANTI-MISSILE TECHNOLOGY TO BE SHARED. US: CLINTON PUTS MISSILE DEFENCE PROJECT ON HOLD
- Abstracts: Eidos signs up Michael Owen UK: EMI DEFENDS HUGE MANAGEMENT PAYOUTS
- Abstracts: UK: SCOTTISH SALMON FARMING MAY BE CURBED. The noble salmon: Wild. Mysterious. Prized above all other fish. And dying out in rivers all over Europe